The FDA has approved adrabetadex (Lembaz) intrathecal injection to reduce mortality in patients with infantile-onset ...
Experts describe how pollution, extreme temperatures, and changing ecosystems may shape autoimmune disease risk — and why ...
Observational studies presented at the American College of Rheumatology (ACR) 2026 Annual Meeting examined the effects of GLP ...
A noninvasive audiovisual stimulation device for Alzheimer’s disease misses the primary endpoint in the phase 3 HOPE trial ...
An expert explains why palliative care focuses on relieving illness-related suffering and supporting patients and families, ...
Discontinuing statins appears noninferior to continuing therapy for cardiovascular event risk in patients aged 70 years or ...
A clinical consensus document from the American College of Rheumatology advises rheumatologists on managing atherosclerotic ...
Novel and modified mechanisms of action to treat inflammatory skin diseases are sufficiently advanced that an expert ...
The diseases, injuries, and risk factors driving the burden of disease in Canada are changing, partly due to an aging ...
Among patients in primary care with abnormal liver function tests, those with steatosis on ultrasound face a higher risk for ...
Those in the highest GREAT score category show significantly lower rates of remission after antithyroid therapy ...
Infants with a chest infection in their first year face substantially higher odds of a parent-reported wheeze or asthma ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results